KM Financial Solutions | SoftBank leads $165 mln capital boost for liquid biopsy firm Karius
66448
post-template-default,single,single-post,postid-66448,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

SoftBank leads $165 mln capital boost for liquid biopsy firm Karius

SoftBank leads $165 mln capital boost for liquid biopsy firm Karius

SoftBank’s second Vision Fund has led a
new $165 million funding round in California-based Karius, which
markets a test that can quickly detect hard to diagnose
infections through a simple taking of blood, the start-up said
on Monday.

No Comments

Sorry, the comment form is closed at this time.